Found: 4
Select item for more details and to access through your institution.
Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. 800, doi. 10.1002/ajh.24415
- By:
- Publication type:
- Article
Resolution of Cullen's sign in patient with metastatic melanoma responding to hypoxia-activated prodrug TH-302.
- Published in:
- 2011
- By:
- Publication type:
- Case Study
A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma.
- Published in:
- Oncology, 2011, v. 80, n. 1/2, p. 50, doi. 10.1159/000327739
- By:
- Publication type:
- Article
Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
- Published in:
- Critical Care, 2023, v. 27, n. 1, p. 1, doi. 10.1186/s13054-023-04446-1
- By:
- Publication type:
- Article